Table 1.
Cancer site | Phase of care |
|||
---|---|---|---|---|
Initial | Continuing | End-of-life |
||
Cancer | Other cause | |||
Bladder | 52 490 | 74 913 | 15 180 | 19 633 |
Brain | 2882 | 2490 | 7845 | 1705 |
Breast | 126 034 | 250 192 | 22 527 | 35 908 |
Cervix uteri | 2238 | 4224 | 1618 | 743 |
Colorectal | 81 226 | 137 618 | 42 023 | 34 596 |
Esophagus | 5275 | 5125 | 8449 | 1689 |
Hodgkin lymphoma | 1450 | 2529 | 854 | 563 |
Kidney | 26 754 | 40 003 | 10 817 | 8160 |
Leukemia | 18 366 | 24 824 | 15 128 | 7389 |
AML | 2226 | 1804 | 7416 | 1041 |
CLL | 11 763 | 17 513 | 3805 | 4344 |
CML | 2598 | 3181 | 1519 | 1225 |
Liver | 5644 | 4968 | 9280 | 2295 |
Lung | 73 836 | 70 089 | 124 277 | 24 747 |
NSCLC | 68 128 | 66 400 | 106 775 | 23 007 |
SCLC | 5708 | 3689 | 17 502 | 1740 |
Melanoma | 64 428 | 97 579 | 7212 | 15 635 |
Myeloma | 11 734 | 13 944 | 9650 | 3733 |
Non-Hodgkin lymphoma | 34 448 | 52 908 | 18 048 | 11 367 |
Oral cavity or pharynx | 15 858 | 23 432 | 8261 | 5277 |
Ovary | 8088 | 11 807 | 10 241 | 1492 |
Pancreas | 8804 | 5321 | 29 571 | 2458 |
Prostate | 158 840 | 335 539 | 23 403 | 48 559 |
Stomach | 9411 | 10 623 | 11 809 | 3333 |
Thyroid | 10 684 | 19 255 | 1688 | 1714 |
Uterus | 22 098 | 42 161 | 7561 | 5804 |
All sites combined | 808 148 | 1 316 976 | 436 986 | 270 816 |
Includes patients diagnosed with in-situ and invasive cancers. AML = acute myeloid leukemia; CLL = chronic lymphocytic leukemia; CML = chronic myeloid leukemia; NSCLC = non-small cell lung cancer; SCLC = small cell lung cancer; SEER = Surveillance, Epidemiology, and End Results Program. The reference source for this table is Mariotto et al., 2020 (4).